RÉSUMÉ
Background Janus kinase (JAK)/tyrosine kinase 2 (TYK2) inhibitors are novel treatments for moderate-to-severe plaque psoriasis. Objective To perform a network meta-analysis to compare the efficacy and safety of TYK2 inhibitors with other oral drugs in moderate-to-severe psoriasis. Methods Eligible randomised clinical trials (RCTs) were identified from public databases (published before November 2, 2023). Random-effect frequentist network meta-analysis was performed with ranking based on the surface under the cumulative ranking curve (SUCRA) of Physician's Global Assessment of "clear" or "almost clear" (PGA 0/1), 75% reduction from baseline in Psoriasis Area and Severity Index (PASI-75). Results Twenty RCTs containing 7,564 patients with moderate-to-severe psoriasis were included. Deucravacitinib at all dose levels (except for 3 mg every other day) and tofacitinib (10 mg BID) ranked best in achieving PGA 0/1 and PASI-75 at 12- 16 weeks. Tofacitinib (10 mg BID) was considered the most unsafe. Analysis of Ranking according to efficacy and safety showed deucravacitinib (3 mg QD and 3 mg BID) was the best treatment. Analysis of Ranking according to efficacy and safety showed deucravacitinib (3 mg QD and 3 mg BID) was the best treatment. Limitations Insufficiency of eligible data and no long-term follow-up data. Conclusion Deucravacitinib showed superior efficacy and safety for treating moderate-to-severe psoriasis over other included drugs.
RÉSUMÉ
Background: Atopic dermatitis (AD) has the highest burden of any skin disease; however, the severity-associated factors remain unclear. Objective: To evaluate potential severity-associated factors of AD and to design and validate a severity prediction model to inform the management of AD patients. Methods: A cross-sectional study of 900 AD patients was conducted from December 2021 to October 2022 at our hospital. The primary outcome was disease severity, categorized as mild, moderate, or severe using the scoring atopic dermatitis index. Ordinal logistic regression and bootstrapped validation were used to derive and internally validate the model. Results: Increasing age, elevated eosinophil level, higher economic status, and urban residence were associated with severe AD. Breastfeeding, disinfectants and topical emollients use, and short duration of bathing were associated with mild AD. In the prediction model, predictors included age, eosinophil and economic status, residence, feeding, disinfectants and emollients use, and duration of bathing. Prediction models demonstrated good discrimination (bias-corrected concordance index [c-index] = 0.72) and good calibration. Conclusion: Risk factors for the severity of AD were identified that could aid the early prediction of AD progression. The predictive model included variables that are easily evaluated and could inform personalized prevention and therapy.
Sujet(s)
Eczéma atopique , Désinfectants , Humains , Études transversales , Eczéma atopique/épidémiologie , Eczéma atopique/étiologie , Émollient , Études rétrospectives , Facteurs de risque , Désinfectants/effets indésirablesRÉSUMÉ
Kaposi sarcoma (KS) is a vascular proliferative tumor caused by human herpesvirus 8. At present, the treatment of KS is difficult and refractory. Here, we report a 68-year-old man who was diagnosed with a classical KS with tinea pedis and onychomycosis, infected by Trichophyton rubrum, and treated with itraconazole and thalidomide after locational excision of several bigger nodules. The lesions were relieved during treatment, and recurred after discontinuation. Retreatment still achieved good effect and the therapy was tapered down after control. After the whole course of treatment, the skin lesions subsided significantly without obvious adverse reactions, which showed that itraconazole combined with thalidomide may be another effective and safe treatment for KS in some cases.
RÉSUMÉ
Elevated serum level of total and (or) allergen-specific IgE is one of the key features of atopic dermatitis (AD). Previous studies have shown that the gut microbiome mediates interactions between external exposures and the immune system in AD; however, the relationship between the gut microbiota and IgE remains unclear. In the present study, analyses of environmental exposures for 250 AD patients and 138 healthy volunteers revealed an association between hygiene levels in the residential environment and the occurrence of AD and the IgE level. Metagenomic sequencing of the gut microbiota from 68 AD patients and 77 healthy controls showed that AD patients had a distinct gut microbiota composition; moreover, while L-histidine degradation was enriched in healthy controls, L-histidine biosynthesis was enriched in AD patients. Extrinsic and intrinsic AD showed different enrichment patterns of specific microbes and differential associations of functional pathways. Our study indicated that elevated levels of IgE in AD were related to specific microbes in the gut microbiota, which showed extensive interactions with environmental factors.
Sujet(s)
Eczéma atopique , Microbiome gastro-intestinal , Humains , Histidine , Métagénome , Immunoglobuline ERÉSUMÉ
BACKGROUND: In chronic spontaneous urticaria (CSU), the guidelines recommend very limited diagnostic procedures during the routine workup, although additional investigations might be indicated in some patients with CSU. For physicians treating patients with CSU, it is often difficult to decide which diagnostic tests are useful. OBJECTIVE: To provide recommendations on what diagnostic tests should be performed on which patients with CSU. METHODS: We performed an extensive literature search on the respective topics and identified relevant questions that should prompt diagnostic procedures based on the published evidence and expert consensus among all authors. RESULTS: We provide questions, diagnostic testing, where appropriate, and recommendation that should be included when assessing the history of a patient with CSU, to explore and rule out differential diagnoses, to assess patients for underlying causes and modifying conditions, to explore patients for comorbid diseases and consequences of having CSU, and to assess patients for CSU components that can help to predict their disease course and response to treatment. CONCLUSIONS: Here, we provide physicians treating patients with CSU with information about which clues should lead to which tests and why.
Sujet(s)
Urticaire chronique , Urticaire , Maladie chronique , Consensus , Évolution de la maladie , Humains , Urticaire/diagnosticRÉSUMÉ
Purpose: Oncofertility care at cancer diagnosis remains underimplemented across oncology and fertility care settings, with limited tools to scale up effective implementation strategies. Using implementation science theory, we systematically assessed factors that influence oncofertility care implementation and mapped scalable strategies, particularly electronic health record (EHR)-enabled ones, that fit adult and pediatric oncology care contexts. Methods: Using purposeful sampling, we recruited health care providers and female, reproductive-aged survivors of adolescent and young adult (AYA) cancers (AYA survivors) from a comprehensive cancer center and a freestanding children's hospital to semistructured interviews and focus groups. Using thematic analysis combining inductive codes with deductive codes using the Consolidated Framework for Implementation Research (CFIR), we characterized barriers and facilitators to care and designed responsive strategies. Two coders independently coded each transcript. Results: We recruited 19 oncology and fertility providers and 9 cancer survivors. We identified barriers and facilitators to oncofertility care in the CFIR domains of individual, inner setting, outer setting, and process, allowing us to conceptualize oncofertility care to encompass three core components (screening, referral, and fertility preservation counseling) and map five strategies to these components that fit an adult and a children's context and bridge oncology and fertility practices. The strategies were screening using a best practice advisory, referral order, telehealth fertility counseling, provider audit and feedback, and provider education. All but provider education were EHR tools with embedded efficiencies. Conclusion: An implementation science approach systematically assessed oncofertility care and mapped strategies to provide a theory-based approach and scalable EHR tools to support wider dissemination.
Sujet(s)
Survivants du cancer , Préservation de la fertilité , Tumeurs , Adolescent , Adulte , Enfant , Femelle , Fécondité , Humains , Tumeurs/thérapie , Survivants , Jeune adulteRÉSUMÉ
Purpose: Sexual minority (SM) individuals experience higher rates of anxiety and depression. Previous research on mental health disparities for SM cancer survivors has largely focused on adult survivors; however, studies are limited in the adolescent and young adult (AYA) population. This study's objective is to compare depression and anxiety symptoms between AYA, female cancer survivors who identify as an SM and those who identify as heterosexual. Methods: A cross-sectional analysis of 1025 AYA survivors aged 18-40 years (2015-2017) was performed. Patients self-reported SM identification and depression and anxiety symptoms, as measured by the Patient Health Questionnaire (PHQ8) and Generalized Anxiety Disorder Scale (GAD7), respectively. Multivariable logistic regression tested associations between SM identification and depression and anxiety. Results: Sixty-four participants (6%) identified as an SM. In adjusted analyses, SM participants had 1.88 higher odds of anxiety (odds ratio [OR] 1.88, confidence interval [95% CI] 1.05-3.35, p = 0.033) compared with heterosexual participants. SM participants did not have significantly higher odds of depression (OR 1.36, CI 0.75-2.47, p = 0.31). More social support was significantly associated with lower odds of depression (OR 0.91, CI 0.89-0.93, p < 0.001) and anxiety (OR 0.93, CI 0.91-0.94, p < 0.001). Conclusions: AYA cancer survivors identifying as an SM had nearly twice the odds of anxiety, with social support that is protective for both anxiety and depression. While mental health screening is recommended throughout the cancer care continuum, these data support the need for reliable screening, clinician awareness of increased vulnerability in the AYA, SM survivor population, and clinician training on culturally competent care and generation of evidence-based interventions.
Sujet(s)
Survivants du cancer , Tumeurs , Minorités sexuelles , Adolescent , Anxiété/épidémiologie , Études transversales , Dépression/épidémiologie , Femelle , Humains , Mâle , , Jeune adulteRÉSUMÉ
OBJECTIVE: Because hot flashes are a common symptom experienced by women with breast cancer, we sought to explore genetic predictors associated with response to acupuncture for the treatment of hot flashes. METHODS: Using data from our completed randomized controlled trial (Clinicaltrials.gov identifier: NCT01005108) on hot flashes among breast cancer survivors who provided biomarker collection (Nâ=â108), we extracted and assayed DNA for single nucleotide polymorphisms in genes involved in neurotransmission, thermoregulation, and inflammation (ADORA1, COMT, TCL1A, and TRPV1). For our primary outcome we classified individuals with a 50% or more reduction in their hot flash composite score at the end of treatment as responders. We used Fisher exact test to identify individual and combined single nucleotide polymorphisms associated with treatment response. RESULTS: Among women (Nâ=â57) who received acupuncture treatment (electro or sham), we found that women who were carriers of at least one of these six genotypes (ADORA1 rs41264025-GA or rs16851029-GG or rs12744240-GT, COMT rs6269-GA, TCL1A rs2369049-GG, and TRPV1 rs8065080-TT) were more likely to respond to acupuncture for hot flashes than noncarriers (70.3% vs 37.5%, Pâ=â0.035). These six genotypes were not associated with response in women (Nâ=â51) who received pharmacological hot flash treatment (gabapentin or placebo pill; 37.5% vs 37.5%, Pâ=â1.0). CONCLUSIONS: In this exploratory, proof of concept study, we identified six genotypes that may predict response to acupuncture for hot flashes in breast cancer survivors. If confirmed by future studies, these findings may inform the development of personalized acupuncture for managing hot flashes.
Sujet(s)
Thérapie par acupuncture , Acupuncture , Tumeurs du sein , Survivants du cancer , Tumeurs du sein/génétique , Tumeurs du sein/thérapie , Femelle , Bouffées de chaleur/génétique , Bouffées de chaleur/thérapie , Humains , Résultat thérapeutiqueRÉSUMÉ
Atopic dermatitis (AD) is often concomitant with increased levels of IgE against not only foreign allergens but also autoallergens. AD patients with autoallergy are likely to be more severe and difficult to treat, and self-reactive IgE might be a contributing factor in the pathogenesis of AD. However, how autoallergens are recognized by the immune system and what immune responses are induced subsequently remain largely unknown. We found that the serum level of IgE against transglutaminase 3 (TGase3) was significantly higher in AD patients than in healthy individuals and was positively correlated with disease severity. The expression of TGase3 in the lesional skin of AD patients was markedly increased compared with that of the controls, and Th2 cytokines and/or allergen promoted the expression of TGase3 in keratinocytes. TGase3 bond monocytes-derived dendritic cells (MoDCs) via dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN), which resulted in the production of IL-6 and activation of the NF-κB signaling pathway in MoDCs; and TGase3-treated MoDCs facilitated Th1 polarization. Moreover, skin inflammation in the mouse model of MC903-induced AD was attenuated when TGase3 was inhibited. In conclusion, TGase3 was revealed as an autoallergen in AD and actively involved in skin inflammation; TGase3-targeting might be a therapeutic strategy for the treatment of AD.
Sujet(s)
Autoantigènes/immunologie , Molécules d'adhérence cellulaire/métabolisme , Eczéma atopique/immunologie , Lectines de type C/métabolisme , Récepteurs de surface cellulaire/métabolisme , Peau/immunologie , Transglutaminases/immunologie , Adolescent , Adulte , Sujet âgé , Animaux , Autoanticorps/sang , Autoanticorps/immunologie , Autoantigènes/sang , Autoantigènes/métabolisme , Études cas-témoins , Molécules d'adhérence cellulaire/immunologie , Cellules cultivées , Enfant , Cellules dendritiques/immunologie , Cellules dendritiques/métabolisme , Eczéma atopique/sang , Eczéma atopique/diagnostic , Eczéma atopique/anatomopathologie , Modèles animaux de maladie humaine , Femelle , Volontaires sains , Humains , Immunoglobuline E/sang , Immunoglobuline E/immunologie , Interleukine-6/immunologie , Interleukine-6/métabolisme , Kératinocytes/immunologie , Kératinocytes/métabolisme , Lectines de type C/immunologie , Activation des lymphocytes , Mâle , Souris , Adulte d'âge moyen , Facteur de transcription NF-kappa B/métabolisme , Culture de cellules primaires , Récepteurs de surface cellulaire/immunologie , Indice de gravité de la maladie , Transduction du signal/immunologie , Peau/cytologie , Peau/anatomopathologie , Lymphocytes auxiliaires Th1/immunologie , Transglutaminases/sang , Transglutaminases/métabolisme , Jeune adulteRÉSUMÉ
Previous studies have shown independently that the skin and gut microbiota are closely associated with atopic dermatitis (AD); however, the microbiota across different habitats of AD patients as an integrated community has not been characterized. In the present study, we comparatively analyzed the structure and function of the microbial communities in the skin, oral cavity, and gut of 172 AD patients and 120 healthy controls through 16S ribosomal RNA gene amplicon sequencing. The skin and oral cavity, but not the gut, of AD patients demonstrated differential reduction in the microbial diversity, and these were distinctly correlated with disease severity. Different degrees of shifts in the community structure were found among different habitats, and the lineage distance between the skin and oral microbiota of AD patients was closer than that observed in the controls. The different habitats of AD patients exhibited site-specific alterations at the genus level, and many oral-specific microbes of AD showed opposing directions of enrichment in the skin and oral cavity. Most interestingly, an inverse association in the functional pathways was found between the skin and oral microbiota of AD patients. Additionally, the alterations of the microbiota in different body sites of AD patients were differentially affected by age.
Sujet(s)
Bactéries/isolement et purification , Eczéma atopique/microbiologie , Microbiote/immunologie , Muqueuse de la bouche/microbiologie , Peau/microbiologie , Adolescent , Adulte , Facteurs âges , Bactéries/génétique , Bactéries/immunologie , Études cas-témoins , Enfant , Enfant d'âge préscolaire , ADN bactérien/isolement et purification , Eczéma atopique/diagnostic , Eczéma atopique/immunologie , Eczéma atopique/anatomopathologie , Femelle , Humains , Nourrisson , Muqueuse intestinale/microbiologie , Mâle , Microbiote/génétique , Adulte d'âge moyen , Phylogenèse , ARN ribosomique 16S/génétique , Indice de gravité de la maladie , Peau/anatomopathologie , Jeune adulteRÉSUMÉ
BACKGROUND: Endocrine measures of ovarian reserve before breast cancer treatment may predict postchemotherapy ovarian function, providing prognostic information at the time of cancer diagnosis. The objectives of this study were 1) to determine whether prechemotherapy levels of antimullerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B (inhB) are associated with the return of ovarian function after chemotherapy and 2) to generate a prognostic score for ovarian recovery in young women with breast cancer. METHODS: A prospective cohort study recruited 109 participants (median age, 39 years; age range, 23-45 years) before chemotherapy from 2 breast clinics and followed them longitudinally. By using time-to-event analysis, the authors tested the association between prechemotherapy AMH, FSH, and inhB levels and the time to return of ovarian function, as measured by menstrual pattern. RESULTS: After a median follow-up of 163 days (range, 4-1009 days) after chemotherapy, 62 participants (57%) experienced return of ovarian function. In adjusted analyses, AMH levels >0.7 ng/mL (hazard ratio, 2.9; 95% confidence interval, 1.5-5.6) and FSH levels ≤10 IU/L (hazard ratio, 4.7; 95% confidence interval, 1.3-16.8) were associated with a shorter time to ovarian recovery, whereas inhB levels were not related. A prognostic score based on age <40 years, AMH >0.7 ng/mL, and body mass index ≥25 kg/m(2) was used to estimate the timing of recovery. CONCLUSIONS: In reproductive-aged women with newly diagnosed breast cancer, prechemotherapy AMH and FSH levels were associated with the return of ovarian function, independent of age. A novel prognostic score incorporating AMH, age, and body size was capable of estimating the time to ovarian recovery. Pending validation, these data support using prechemotherapy ovarian reserve measures, particularly AMH, to prospectively counsel young patients on future ovarian function. Because ovarian function is not equivalent to fertility, follow-up studies on predicting fertility are needed.
Sujet(s)
Hormone antimullérienne/sang , Antinéoplasiques/effets indésirables , Tumeurs du sein/traitement médicamenteux , Carcinome canalaire du sein/traitement médicamenteux , Carcinome lobulaire/traitement médicamenteux , Infertilité féminine/induit chimiquement , Réserve ovarienne , Insuffisance ovarienne primitive/induit chimiquement , Adulte , Facteurs âges , Mensurations corporelles , Études de cohortes , Oestradiol/sang , Femelle , Hormone folliculostimulante/sang , Humains , Infertilité féminine/sang , Inhibines/sang , Études longitudinales , Adulte d'âge moyen , Insuffisance ovarienne primitive/sang , Pronostic , Modèles des risques proportionnels , Études prospectives , Récupération fonctionnelle , Appréciation des risques , Jeune adulteRÉSUMÉ
OBJECTIVE: To explore the effects of histidine kinase gene CHK1 on some biological characteristics of Candida albicans. METHODS: The effects of gene mutation strains of Candida albicans such as CHK21, CHK25, CHK26 and CHK27 were observed on its reproductive ability, formation of chlamydospore and germ tube and tolerance of Congo red. RESULTS: The reproductive ability in CHK gene mutation strains CHK25, CHK26, CHK27, CHK21 was weaker than that of wild strains(6 h:1.36 ± 0.86,1.25 ± 0.84,1.05 ± 0.79,0.90 ± 0.74 vs 1.54 ± 0.89,P = 0.000).And CHK21 was the most obvious. The formation of germ tube in CHK gene mutation strains CHK21, CHK25, CHK26 and CHK27 was weaker than that of wild strains (2 h: 5.6% ± 2.0%,19.5% ± 6.9%,13.6% ± 4.8% vs 29.6% ± 10.5%,P = 0.023, 0.028, 0.029).Under no light, the mean number of chlamydospore in wild and CHK26 strains was 3 and 22 respectively. With light, the mean number was changed to 60 and 80. So the formation ability of chlamydospore in CHK26 was stronger than other strains. CHK21 could not produce chlamydospore under no light. The mutation strain of CHK1 was sensitive to Congo red. CONCLUSION: CHK1 affect the reproduction and formation of chlamydospore and hypha and the tolerance to some environmental pressures of Candida albicans.